A hopeful therapy for Niemann-Pick C diseases - The Lancet

Full article: New therapies in the management of Niemann-Pick type

eBioMedicine, June 2023, Volume 92

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological

Frontiers Advances in CRISPR/Cas gene therapy for inborn errors

PDF) Identification of Niemann–Pick C1 (NPC1) disease biomarkers

IJMS, Free Full-Text

Advances in therapies for neurological lysosomal storage disorders

Families plead with FDA for drug to treat Niemann-Pick Disease Type C

A first therapy for Niemann-Pick C - The Lancet Neurology

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological

Understanding the phenotypic variability in Niemann-Pick disease

Biomedicines, Free Full-Text